Evergreen Herbal

Licensees gave another round of feedback to agency staff engaged in rulemaking on how to set limits and requirements for cannabis product sampling by retail staff.

Staff heard stakeholder feedback as they hoped to simplify cannabis sample rules while also improving accountability around how product samples were utilized within the sector.

The sponsor made reasoned arguments for producer-led cannabis research, but industry members were divided over whether the time was right for a cannabis commodity commission.

Feedback on a bill to legalize out-of-state cannabis license ownership was divided: some companies anticipated benefits while others viewed the move as only helping larger entities.

Several cannabis retailers told lawmakers licensed businesses were diverting products to illegal cannabis markets while calling for enforcement, licensing, and reporting changes.

The WSDA Legislative Liaison reviewed department work impacting hemp and cannabis rules before taking questions about staffing and issues expected in the 2023 legislative session.

A last-minute hearing on a repackaged bill to regulate synthesized cannabinoids revealed shared public health concerns but testimony otherwise remained just as sharply divided.

Two visions for the future of cannabinoid regulation were presented to senators, with testimony split between a measure developed by WACA members and WSLCB request legislation.

Sharply divided testimony on a bill to add more members and non-voting legislators to the WSLCB board suggested the idea was controversial in both the cannabis and alcohol sectors.

Testimony on a craft cannabis endorsement was weighted in favor of those who saw the proposal increasing fairness in the cannabis market, but others were not so sure.